EXCLUSIVE

Single-use is the future of biomanufacturing: report from Interphex

Loading the player...

Advancements in single-use equipment are crucial to the development of the biotechnology industry, according to experts at this year’s Interphex.

Speaking to in-PharmaTechnologist at the conference in New York, experts from five Big Pharma firms – GE Healthcare, Pall, Sartorius Stedim, Novasep and IMA – cheered the quick turn-around time of disposable tech.

And whilst some heralded the time and cost benefits of using processing and manufacturing tech once, others championed the new possibilities it creates.

Ian Sellick, director of marketing at Pall, said: “It allows you to throw away some of the old methods of doing things because you no longer have to worry about re-using equipment simply because you’re not going to have to use that equipment a second time.

“An example of that is in protein concentration, where you can now concentrate proteins in line without having to worry whether the membranes are suitable for re-use afterwards.”

However, whilst it seems throwaway equipment is the dish of the day, Sartorius Stedim key account manager Floris De Smet warned that there are possible stumbling blocks.

He said that companies should be diligent when it comes to the supply chain for the parts.

Related News

in-Pharmatechnologist.com's review of Interphex 2012

in-Pharmatechnologist.com's review of Interphex 2012

The single-use age has dawned, says ThermoFisher

The single-use age has dawned, says ThermoFisher

Pall third-quarter earnings hit by ERP system switch disruption

New ERP causes “self-inflicted disruption” of supply at Pall

Novasep, ADC, HPAPI, CMO, Pfizer, Seattle Genetics, Takeda, Millennium

Novasep latest firm to invest in ADC capacity

Catalent to replace steel bioreactors with single use

Catalent plans single use overhaul of bioreactors

Sartorius opens bigger bioreactor plant

Sartorius opens new bioreactor plant to boost capacity

Filters a money spinner for Sartorius Stedim Biotech in 2012

Sartorius Stedim Biotech launches new 'nanofleece' prefilters for bioprocessing

Marshmallow toasting opportunities en route to Interphex in 2010

Lack of Lava-Proof Planes Wont Stop Us Going to Interphex

Drug Industry gathers for Interphex 2013 - Check for live updates

Drug Industry gathers for Interphex 2013 - Check for live updates

ASI and Chromatan talk Single-use at NY Interphex

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

IPPT Buys IMA's Kilian Citing Tech and Asia

Romaco Owner IPPT Buys IMA's Kilian Citing Tech and Asian Reach

Plastic not so fantastic? Single-use systems have their own environmental problems

Plastic not fantastic but single-use is still greener, says industry

Ealier this year, we called on readers to help assess the state of our industry. Image: iStock/TCmake_photo

State of the biopharma industry: the double-edged sword of single-use

UPDATE: Last leg of Achema

Achema 2012: Safety, efficiency and single-use technology

Latest developments in biomanufacturing tech

Latest developments in biomanufacturing tech

EMD Millipore talks single use technology at Interphex 2011

EMD Millipore talks single use technology at Interphex 2011

GE to buy Xcellerex in latest biomanufacturing-focused investment

GE to buy Xcellerex in latest biomanufacturing-focused investment

Fujifilm acquires Merck BioManufacturing Network

Lonza announces CHF10m Singapore biomanufacturing expansion

SSB teams with Refine Technology to improve connectivity in biomanufacturing

SSB teams with Refine Technology to improve connectivity in biomanufacturing

GE Healthcare to invest in biomanufacturing tech

Single-use bioprocess demand drives Sartorius’ sales jump

Single-use bioprocess demand drives Sartorius’ sales jump

Retrofitting plants with single-use systems boots flexibility; AAPS panel

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.